Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Newsletter | June 2, 2021 By Ed Miseta, chief editor, Clinical Leader At some point, every pharma and biotech company hoping for a regulatory approval will have to start planning for commercialization. That planning can start at different phases of the drug development process, but historically it has often been delayed until clinical trials were well underway. At least one executive believes that planning should happen earlier in the development cycle.
By Phyllis Kaplan and Joan Chambers, CISCRP While the clinical trials industry has made incredible strides raising awareness among the broader general population, as we’ve witnessed firsthand amid the ongoing COVID-19 pandemic, there remains a persistent lack of representation in clinical research among diverse communities. For decades, people of color have largely chosen not to participate in clinical trials.
If you answer yes, or even maybe, to any of these questions I hope you'll consider attending the Camp Nejeda Survive and Thrive weekend for adults with T1D and their Plus 1 in September: 1. Does diabetes sometimes feel like it is a ‘third wheel’ in your relationship? Is T1D a presence in the room that neither of you have the words to discuss? 2. Do you wish your significant other would worry less and care more about your physical as well as emotional health and well-being? 3.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
